Through their function in Toll-like receptor (TLR) and interleukin 1 receptor (IL-1R) mediated signaling pathways, interleukin-1 receptor-associated kinases (IRAKs), which are serine/threonine kinases, play critical roles in initiating innate immune responses against foreign pathogens and other types of dangers. Two active kinases, IRAK-1 and IRAK-4, and two inactive kinases, IRAK-2 and IRAK-M, are among the four distinct IRAK-like molecules that have been discovered. Nuclear factor-kappaB (NF-B) and mitogen-activated protein kinase (MAPK) pathways are both activated by all IRAKs.
The adaptor molecule MyD88 and the IRAK-1, 2, M, and 4 members of the IL-1R-associated kinase family are used by toll-like receptors to transmit their signals. The Myddosomes formed by MyD88-IRAK-4, IRAK-1, and IRAK-2 are known to mediate TLR7-induced, TAK1-dependent NF-B activation. It is known that IRAK-M acts as a negative regulator, preventing the dissociation of IRAKs from MyD88 and obstructing subsequent signaling.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V75060 | PF-06426779 | 1817628-40-2 | PF-06426779 is a potent and specific inhibitor of interleukin-1 receptor-associated kinase 4 (IRAK4) with IC50 of 0.3 nM. |
|
V75056 | PROTAC IRAK4 degrader-8 | 2911615-06-8 | PROTAC IRAK4 degrader-8 (compound 2) is a PROTAC targeting IRAK4 (IC50=15.5 nM). |
|
V4593 | Takinib | 1111556-37-6 | Takinib is a novel, potent and selectiveTAK1inhibitor with anIC50of 9.5 nM. |
|
V75052 | Zabedosertib (BAY 1834845) | 1931994-81-8 | Zabedosertib (BAY 1834845) is an IRAK4 inhibitor (antagonist) with immunomodulatory potential. |
|
V4562 | Zimlovisertib (PF06650833) | 1817626-54-2 | PF06650833 is a novel, potent and selective inhibitor ofInterleukin-1 receptor associated kinase 4 (IRAK4) which is used to treat autoimmune diseases such as rheumatoid arthritis, lupus, and lymphomas. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
